Nicholas Larkins
Overview
Explore the profile of Nicholas Larkins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lim Z, Taverniti A, Downing J, Le C, Lopez P, Larkins N, et al.
HLA
. 2024 Dec;
104(6):e15784.
PMID: 39637319
HLA-compatibility remains an important triage test for deceased donor kidney allocation. Low-intermediate resolution donor HLA-typing is typically available at allocation, but its accuracy in assigning pre-transplant donor-specific anti-HLA antibody (DSA)...
2.
Guha C, Khalid R, Mallitt K, van Zwieten A, Francis A, Kim S, et al.
Kidney Int Rep
. 2024 Nov;
9(11):3177-3189.
PMID: 39534191
Introduction: Inequitable access to health care based on demographic factors such as ethnicity, socioeconomic status and geographical location has been consistently found in children with chronic kidney disease (CKD). However,...
3.
Wong G, Guha C, Mallitt K, van Zwieten A, Khalid R, Francis A, et al.
Kidney Int
. 2024 Jul;
106(4):736-748.
PMID: 38959996
Patient navigators enable adult patients to circumnavigate complex health systems, improving access to health care and outcomes. Here, we aimed to evaluate the effects of a patient navigation program in...
4.
Bihlet A, Byrjalsen I, Andersen J, Reynolds A, Larkins N, Alexandersen P, et al.
Osteoarthritis Cartilage
. 2024 May;
32(7):952-962.
PMID: 38697511
Objective: Apocynin (AP) and paeonol (PA) are low molecular weight phenolic compounds with a broad array of anti-inflammatory and immunoregulatory effects. This study assessed of a fixed-dose combination of APPA...
5.
Fernandez-Moreno M, Hermida-Gomez T, Larkins N, Reynolds A, Blanco F
Pharmaceuticals (Basel)
. 2024 Jan;
17(1).
PMID: 38256951
Osteoarthritis (OA) is a chronic joint disease leading to cartilage loss and reduction in the joint space which results in pain. The current pharmacological treatment of OA is inadequate and...
6.
Prunster J, Wong G, Larkins N, Wyburn K, Francis R, Mulley W, et al.
Clin Kidney J
. 2023 Mar;
16(3):473-483.
PMID: 36865004
Background: The Kidney Donor Profile Index (KDPI) is routinely reported by the donation agencies in Australia. We determined the association between KDPI and short-term allograft loss and assessed if this...
7.
van Zwieten A, Ryan E, Caldwell P, Howard K, Tong A, Craig J, et al.
Trials
. 2022 Sep;
23(1):824.
PMID: 36175942
Background: This update summarises key changes made to the protocol since the publication of the original protocol for the NAVKIDS trial of patient navigators for children with chronic kidney disease...
8.
Soraru J, Sheriff D, Rajakaruna R, Larkins N
Nephrology (Carlton)
. 2022 Mar;
27(7):641-642.
PMID: 35289023
No abstract available.
9.
Lim W, Adams B, Alexander S, Bouts A, Claas F, Collins M, et al.
BMC Nephrol
. 2021 Dec;
22(1):416.
PMID: 34923958
Background: Parental donor kidney transplantation is the most common treatment option for children and adolescents with kidney failure. Emerging data from observational studies have reported improved short- and medium-term allograft...
10.
Francis A, Prestidge C, Kausman J, Le Page A, Larkins N, McCarthy H
Pediatr Nephrol
. 2021 Oct;
37(5):1149-1156.
PMID: 34709476
Background: Limited data suggest children with secondary steroid-resistant nephrotic syndrome (secondary SRNS) have increased risk of recurrence post transplantation. There are no data on the association between secondary steroid resistance...